Abbreviation used: LCMV, lymphocytic choriomeningitis virus.

When a naive CD8^+^ T cell encounters antigen, it undergoes vigorous clonal expansion and differentiation into a population comprised primarily of short-lived, cytotoxic effectors that undergo cell death after pathogen is cleared ([@bib1]). The elimination of the antigen-experienced progeny of a selected T cell clone, however, is generally incomplete, ensuring preservation of a portion of daughter cells to provide a "memory" of the pathogen encounter. At least two functionally distinct classes of memory cells have been described, based on their pattern of tissue homing in the absence of antigen. Effector--memory CD8^+^ T cells provide protection against reinfection by patrolling peripheral tissues, but have a poor capacity for homeostatic renewal and secondary proliferation. Central--memory CD8^+^ T cells, in contrast, recapitulate the surveillance behavior of their naive predecessor by migrating through secondary lymphoid organs; they are distinguished by efficient homeostatic renewal and rapid secondary proliferative responses to generate cytotoxic effectors upon reencounter with pathogen ([@bib2], [@bib3]). It remains controversial whether commitment to the self-renewing, central--memory lineage occurs before or after adoption of the effector fate ([@bib3]--[@bib6]).

The intrinsic molecular program that directs commitment to the effector-- versus central--memory CD8^+^ T cell lineage is not fully understood. We found that deficiency of the transcription factor T-bet resulted in defective generation of effector--memory CD8^+^ T cells and excessive generation of central--memory CD8^+^ T cells. The enhanced central--memory formation resulting from T-bet deficiency directly contrasted with the defective central--memory formation occurring in the absence of CD4^+^ T cell help. Deletion of T-bet prevented the defective phenotypic and functional characteristics of unhelped CD8^+^ T cells. These results suggest that T-bet may represent a novel target for manipulating the balance between terminal differentiation and self-renewal of pathogen-specific CD8^+^ T cells.

RESULTS AND DISCUSSION
======================

T-bet represses IL-7Rα in effector CD8^+^ T cells
-------------------------------------------------

During the acute phase of an infection, repression of IL-7Rα marks pathogen-specific CD8^+^ T cells destined for elimination, whereas the cells that will give rise to self-renewing memory CD8^+^ T cells seem to be contained within the IL-7Rα--expressing subset ([@bib7], [@bib8]). When we examined the lymphocytic choriomeningitis virus (LCMV)--specific CD8^+^ T cell response in T-bet--deficient mice, we observed defective repression of IL-7Rα at day 8 after infection ([Fig. 1 A](#fig1){ref-type="fig"}). Because this finding suggested that T-bet may function as a repressor of IL-7Rα, we tested whether T-bet was sufficient to repress IL-7Rα in T cells. Retroviral-mediated expression of T-bet in CD8^+^ or CD4^+^ T cells stimulated in vitro resulted in repression of IL-7Rα mRNA ([Fig. 1 B](#fig1){ref-type="fig"}). In addition, ectopic expression of T-bet in developing Th2 cells in which T-bet is not normally expressed resulted in repression of IL-7Rα surface expression ([Fig. 1 C](#fig1){ref-type="fig"}).

![**T-bet--mediated repression of IL-7Rα in effector CD8^+^ T cells.** (A) IL-7Rα expression on CD8^+^ T cells from blood of wild-type or *Tbx21* ^−/−^ mice 8 d after LCMV infection. Top row shows CD8^+^ T cells; middle and bottom rows show H-2D^b^GP33^+^ or H-2D^b^NP396^+^ T cells, respectively; the percentage of events are indicated. (B) Quantitative RT-PCR (Q-PCR) of IL-7Rα mRNA from P14 CD8^+^ (left) or DO11.10 CD4^+^ (right) T cells stimulated with peptide plus APCs and transduced with retrovirus. Cells sorted 5 d after transduction based on GFP. (C) IL-7Rα expression on DO11.10 CD4^+^ T cells in T~H~2 conditions stimulated and transduced as in B. Cells stained 5 d after transduction. (D) Q-PCR of P14 CD8^+^ T cells from spleens 8 d after infection sorted for IL-7Rα^hi^ or IL-7Rα^lo^ expression. Naive (CD44^lo^) CD8^+^ T cells are included in some graphs for reference. (E and F) Q-PCR of T-bet, Eomes, or Blimp-1 mRNA in LCMV-specific CD8^+^ T cells. H-2D^b^GP33^+^ plus H-2D^b^NP396^+^ CD8^+^ T cells sorted from spleens of wild-type mice at the indicated day after infection. Unfractionated tetramer-positive cells (E) or tetramer-positive cells fractionated by CD62L^hi^ or CD62L^lo^ expression (F). Values for Q-PCR represent the mean ± the SEM of triplicate determinations, normalized to HPRT. All results are representative of at least three experiments.](jem2042015f01){#fig1}

The identification of T-bet as a repressor of IL-7Rα prompted us to test whether T-bet expression is associated with the IL-7Rα^lo^ subset of effector CD8^+^ T cells. We sorted LCMV-specific P14 CD8^+^ T cells 8 d after infection on the basis of IL-7Rα expression and examined T-bet mRNA. T-bet was enriched in the IL-7Rα^lo^ subset of effector CD8^+^ T cells, whereas the IL-7Rα^hi^ subset had reduced expression of T-bet mRNA ([Fig. 1 D](#fig1){ref-type="fig"}) and protein (not depicted). A similar pattern of gene expression was observed in IL-7Rα^hi^ and IL-7Rα^lo^ cells from the endogenous LCMV-specific CD8^+^ T cell response (not depicted).

In addition to elevated expression of T-bet, the IL-7Rα^lo^ subset of effector CD8^+^ T cells exhibited substantial enrichment for KLRG1 mRNA ([Fig. 1 D](#fig1){ref-type="fig"}) and protein (not depicted). KLRG1 is an NK-like inhibitory receptor that marks replicative senescence in CD8^+^ T cells ([@bib7], [@bib9]) and whose expression in NK cells is dependent on T-bet ([@bib10]). In contrast, IL-7Rα^lo^ effectors had reduced expression of CCR7 mRNA ([Fig. 1 D](#fig1){ref-type="fig"}), which is a chemokine receptor that represents a defining feature of central--memory CD8^+^ T cells ([@bib2], [@bib3]). In addition, we discovered that the IL-7Rα^lo^ subset exhibited elevated expression of Blimp-1 mRNA ([Fig. 1 D](#fig1){ref-type="fig"}), a transcriptional repressor that promotes terminal differentiation of plasma cells ([@bib11]) and that may also function in T lymphocytes ([@bib12], [@bib13]). Thus, enhanced expression of T-bet appears to selectively mark IL-7Rα^lo^ effector CD8^+^ T cells, which exhibit features of terminal differentiation and which have previously been shown to fail to give rise to self-renewing memory cells ([@bib7], [@bib8]).

Cell transfer experiments have suggested that the IL-7Rα^lo^ subset of effector CD8^+^ T cells preferentially gives rise to effector--memory cells ([@bib7]). Consistent with this potential lineage relationship, we found that T-bet was enriched in effector--memory CD8^+^ T cells ([Fig. 1, E and F](#fig1){ref-type="fig"}). The skewing of T-bet expression in effector-- versus central--memory cells was also recently reported in human memory CD8^+^ T cells ([@bib14]). Given the variety of haploinsufficient phenotypes resulting from hemizygous deletion of T-bet, it is possible that the differences in the amount of T-bet between IL-7Rα^lo^ versus IL-7Rα^hi^ effectors and central-- versus effector--memory CD8^+^ T cells could be functionally relevant ([@bib15]--[@bib19]). Expression of Blimp-1 paralleled that of T-bet, with elevated expression in the effector--memory CD8^+^ T cell subset ([Fig. 1, E and F](#fig1){ref-type="fig"}). Eomes expression, in contrast, did not vary substantially between IL-7Rα^hi^ and IL-7Rα^lo^ ([Fig. 1 D](#fig1){ref-type="fig"}) or central-- and effector--memory subsets ([Fig. 1, E and F](#fig1){ref-type="fig"}).

T-bet deficiency results in enhanced generation of central--memory CD8^+^ T cells
---------------------------------------------------------------------------------

The expression pattern of T-bet and its role in repressing IL-7Rα suggested that T-bet might negatively regulate the development of central--memory CD8^+^ T cells. We found that loss of T-bet, in addition to causing derepression of IL-7Rα, resulted in effector CD8^+^ T cells that acquired several characteristics of central--memory cells, including high expression of CD27, low expression of KLRG1, and robust IL-2 production ([Fig. 2, A and C](#fig2){ref-type="fig"}) ([@bib16], [@bib20]). 30 d after infection, LCMV-specific CD8^+^ T cells from wild-type mice exhibited substantial heterogeneity ([Fig. 2 B](#fig2){ref-type="fig"}), which is consistent with the presence of both central-- and effector--memory CD8^+^ T cells ([@bib2], [@bib3], [@bib5]). In contrast, T-bet--deficient mice exhibited a predominance of central--memory CD8^+^ T cells ([Fig. 2, B and C](#fig2){ref-type="fig"}). T-bet--deficient memory CD8^+^ T cells also exhibited a gene expression pattern similar to central--memory cells, with increased CCR7, reduced Blimp-1, and elevated Eomes mRNA ([Fig. 2, D and E](#fig2){ref-type="fig"}).

![**Enhanced generation of central--memory CD8^+^ T cells in T-bet--deficient mice.** (A--C) Phenotype of GP33-specific CD8^+^ T cells from spleens of wild-type or *Tbx21* ^−/−^ mice 8 (A), 30 (B), or 140 d (C) after LCMV infection. Plots display H-2D^b^GP33^+^ events; the percentage of events are indicated. For bottom row, splenocytes were stimulated with GP~33-41~ peptide; numbers indicate the percentage producing both IFN-γ and IL-2. Results are representative of three experiments with multiple mice per time point. (D and E) Q-PCR of H-2D^b^GP33^+^ plus H-2^b^NP396^+^ CD8^+^ T cells from spleens of wild-type or *Tbx21* ^−/−^ mice. (D) CCR7 and Blimp-1 mRNA 60 d after infection. Naive represents CD44^lo^CD8^+^ T cells from uninfected wild-type mice. (E) Eomes mRNA 60 and 100 d after infection. Day 0 represents CD44^lo^CD8^+^ T cells from uninfected wild-type or *Tbx21* ^−/−^ mice. Results are representative of three similar experiments. (F) Quantification of LCMV-specific CD8^+^ T cells from wild-type or *Tbx21* ^−/−^ mice 8, 30, and 60 d after infection. Left graph shows H-2D^b^GP33^+^ cells as the percentage of CD8^+^ in blood. Middle and right graphs show numbers of CD8^+^ T cells from spleen or lymph node (pooled axillary, inguinal, cervical, paraaortic, and mesenteric), respectively, producing IFN-γ in response to GP~33-41~. Results represent the mean ± the SEM for at least three mice per data point.](jem2042015f02){#fig2}

It was previously suggested that T-bet functions as a positive regulator of memory CD8^+^ T cell development because T-bet--deficient mice were found to have decreased numbers of LCMV-specific memory CD8^+^ T cells in the blood and spleen ([@bib16]). In the memory phase of the response (30 and 60 d after infection), we also found that *Tbx21* ^−/−^ mice had fewer LCMV-specific CD8^+^ T cells in the blood and spleen ([Fig. 2 F](#fig2){ref-type="fig"} and Fig. S1, available at <http://www.jem.org/cgi/content/full/jem.20070841/DC1>). Despite the deficiency in the blood and spleen, *Tbx21* ^−/−^ mice were found to have increased numbers of memory cells in the lymph nodes. This might be partially attributable to the elevated expression of CCR7 in *Tbx21* ^−/−^ CD8^+^ T cells ([Fig. 2 D](#fig2){ref-type="fig"}). To ensure that the phenotype of T-bet deficiency was CD8^+^ T cell--intrinsic, we used a transfer system in which the behavior of both wild-type and *Tbx21* ^−/−^ P14 CD8^+^ T cells could be studied within the same wild-type host (Fig. S2). This system recapitulated the phenotypic, functional, and anatomic characteristics observed in the endogenous CD8^+^ T cell response of *Tbx21* ^−/−^ mice. Together, these results suggest that T-bet inhibits the formation of lymph node--homing, central--memory CD8^+^ T cells and positively regulates the development of effector--memory CD8^+^ T cells.

Two features of central--memory CD8^+^ T cells are their robust capacity for secondary proliferation and an ability to confer heightened resistance to reinfection. Therefore, we assessed these characteristics in *Tbx21* ^−/−^ memory CD8^+^ T cells by transferring equal numbers of GP33-specific wild-type or *Tbx21* ^−/−^ memory CD8^+^ T cells into naive wild-type recipients and challenging with *Listeria monocytogenes* expressing GP~33-41~. T-bet--deficient memory CD8^+^ T cells exhibited severalfold greater reexpansion than wild-type cells upon rechallenge ([Fig. 3 A](#fig3){ref-type="fig"}) and were found to express IL-2 at a greater frequency ([Fig. 3, A and B](#fig3){ref-type="fig"}). Mice that received *Tbx21* ^−/−^ memory CD8^+^ T cells also showed substantially reduced bacterial burdens in both spleen and liver compared with recipients of wild-type cells ([Fig. 3 C](#fig3){ref-type="fig"}). Thus, deletion of T-bet promotes the development of highly functional memory CD8^+^ T cells. Presently, we are unsure why the defect in effector--memory CD8^+^ T cells resulting from deficiency of T-bet appears more permanent in this study compared with prior findings ([@bib16]), although the operational definitions of effector--memory differ (phenotypic/functional versus chemokine receptor) in the two studies.

![**Enhanced secondary expansion and protection of T-bet--deficient memory cells.** Equal numbers (2 × 10^5^) of wild-type or *Tbx21* ^−/−^ GP33-specific CD8^+^ T cells (Thy1.2^+^) isolated 45 d after LCMV infection and transferred to naive wild-type recipients (Thy1.1^+^). 1 d after transfer, recipient mice were infected with 2.5 × 10^5^ CFU of *L. monocytogenes*. 4 d after challenge, spleens and livers were harvested to assess CD8^+^ T cell expansion and perform quantitative bacterial cultures. (A) Wild-type or *Tbx21* ^−/−^ GP33-specific CD8^+^ T cell expansion. Graphs display numbers of transferred cells (Thy1.2^+^) from spleens of recipient mice producing IFN-γ or IL-2 in response to GP~33-41~. (B) Cytokine production by wild-type or *Tbx21* ^−/−^ GP33-specific CD8^+^ T cells from spleens of recipient mice. Plots display CD8^+^ events; numbers indicate the percentage of cells producing both IFN-γ and IL-2 in response to GP~33-41~. (C) Bacterial load in mice that received wild-type or *Tbx21* ^−/−^ GP33-specific CD8^+^ T cells. Spleens and livers were homogenized in 1% Triton X-100. Bacteria quantified by limiting dilution culture. Data for A and C represent the mean ± the SEM of six recipients of wild-type and four recipients of *Tbx21* ^−/−^ cells. Results are representative of three similar experiments.](jem2042015f03){#fig3}

Dysregulated T-bet expression and impaired central--memory CD8^+^ T cell formation in the absence of CD4^+^ T cell help
-----------------------------------------------------------------------------------------------------------------------

A well-characterized model of defective memory CD8^+^ T cell development involves CD8^+^ T cell activation in the absence of CD4^+^ T cell help ([@bib21]--[@bib25]). We examined the properties of "unhelped" CD8^+^ T cells by transfer of P14 CD8^+^ T cells into *Cd4* ^−/−^ recipients ([Fig. 4](#fig4){ref-type="fig"}) or recipients depleted of CD4^+^ T cells using monoclonal antibody injection ([Fig. 5](#fig5){ref-type="fig"}, Fig. S3 \[available at <http://www.jem.org/cgi/content/full/jem.20070841/DC1>\], and not depicted).8 d after infection, there was no difference in the properties of P14 CD8^+^ T cells in wild-type compared with *Cd4* ^−/−^ hosts (not depicted). Several weeks after infection, however, P14 CD8^+^ T cells from *Cd4* ^−/−^ hosts began to manifest signs of aberrant memory differentiation, with impaired expression of CD62L, IL-7Rα, CD27, and IL-2, and elevated expression of KLRG1 ([Fig. 4 A](#fig4){ref-type="fig"}).

![**Enhanced T-bet expression in unhelped memory CD8^+^ T cells.** (A) Phenotype of P14 cells from wild-type or *Cd4* ^−/−^ hosts 60 d after infection. For bottom row, splenocytes were stimulated with GP~33-41~. Plots show CD8^+^ events; numbers indicate the percentage of P14 cells (Thy1.1^+^) expressing indicated surface marker or cytokine. (B and C) Intranuclear T-bet staining of P14 cells from wild-type or *Cd4* ^−/−^ hosts 75 d after infection. (B) Plots show CD8^+^ events; numbers indicate MFI of T-bet staining in bulk P14 population (Thy1.1^+^). (C) Plots show P14 cells (Thy1.1^+^) from *Cd4* ^−/−^ hosts; numbers represent MFI of T-bet staining in subsets with high or low expression of indicated marker. (D) Q-PCR of T-bet and Eomes mRNA in P14 cells from wild-type or *Cd4* ^−/−^ hosts 60 d after infection. (E) Q-PCR of CCR7 and Blimp1 mRNA in P14 cells from wild-type or *Cd4* ^−/−^ hosts 31, 46, or 60 d after infection. Values for Q-PCR represent the mean ± the SEM of triplicate determinations, normalized to HPRT. All results are representative of at least three experiments.](jem2042015f04){#fig4}

![**T-bet--dependent dysfunction of unhelped memory CD8^+^ T cells.** (A and B) Wild-type or *Tbx21* ^−/−^ mice were left untreated (No Tx) or treated with CD4-depleting antibody (0.2 mg GK1.5 i.p.; CD4 depleted) 1 d before and 1 d after LCMV infection. (A) Surface phenotype of GP33-specific CD8^+^ T cells from spleens 90 d after infection. Plots show H-2D^b^GP33^+^ events; numbers represent the percentage of tetramer-positive cells expressing indicated surface marker. (B) Cytokine production of GP33-specific CD8^+^ T cells. Plots show CD8^+^ events; numbers indicate the percentage of cells producing both IFN-γ and IL-2 or CD40L in response to GP~33-41~. Results are representative of two independent experiments.](jem2042015f05){#fig5}

The memory cells arising in the absence of CD4^+^ T cell help appeared to be more effector--memory--like, thus contrasting with T-bet--deficient memory CD8^+^ T cells, which appear to be more central--memory--like. Using intranuclear staining of the T-bet protein, unhelped memory CD8^+^ T cells exhibited a detectable increase in expression of T-bet ([Fig. 4 B](#fig4){ref-type="fig"}), which specifically localized to the expanded effector--memory--like subset (CD62L^lo^, IL-7Rα^lo^, CD27^lo^, KLRG1^hi^; [Fig. 4 C](#fig4){ref-type="fig"} and Fig. S4, available at <http://www.jem.org/cgi/content/full/jem.20070841/DC1>). In addition to exhibiting elevated T-bet mRNA ([Fig. 4 D](#fig4){ref-type="fig"}), unhelped memory CD8^+^ T cells were found to express more Blimp-1 mRNA, but less CCR7 and Eomes mRNA ([Fig. 4, D and E](#fig4){ref-type="fig"}). Lack of CD4^+^ T cell help, thus, appears to impair central--memory and/or promote effector--memory CD8^+^ T cell development.

T-bet deletion prevents dysfunctional programming of unhelped memory CD8^+^ T cells
-----------------------------------------------------------------------------------

To discriminate whether elevated T-bet expression in unhelped memory CD8^+^ T cells plays a causal role in, or is simply a consequence of, their altered differentiation, we performed antibody depletion of CD4^+^ T cells from wild-type or *Tbx21* ^−/−^ mice, followed by infection with LCMV. Again, we found that unhelped memory CD8^+^ T cells in wild-type mice exhibited a predominance of effector--memory--like cells (CD62L^lo^, IL-7Rα^lo^, CD27^lo^ ~,~ and KLRG1^hi^), with impaired production of IL-2 and CD40L ([Fig. 5, A and B](#fig5){ref-type="fig"}, and Fig. S3). Deletion of T-bet, however, prevented the phenotypic and functional defects associated with the lack of CD4^+^ T cell help ([Fig. 5](#fig5){ref-type="fig"}, Fig. S3, and Fig. S5, available at <http://www.jem.org/cgi/content/full/jem.20070841/DC1>), resulting in enhanced generation of central--memory CD8^+^ T cells, regardless of the availability of CD4^+^ T cell help. The rescue was apparent even when T-bet deficiency was confined to antigen-specific CD8^+^ T cells (Fig. S5). Moreover, delayed antagonism of T-bet after unhelped memory CD8^+^ T cell development was capable of reversing several aspects of their dysfunctional phenotype (Fig. S6). Thus, T-bet appears to be required for the aberrant differentiation of memory CD8^+^ T cells that occurs in the absence of CD4^+^ T cell help.

How T-bet and CD4^+^ T cells execute their opposing effects on the balance between central-- versus effector--memory CD8^+^ T cells remains to be determined. In several different systems, transcription factors function as intrinsic modulators of self-renewal or terminal differentiation. In B lymphocytes, the transcriptional repressor Blimp-1 promotes terminal differentiation (plasma cell) at the expense of self-renewal (memory B cell) ([@bib11]). In the *Drosophila melanogaster* neural stem cells, the homeodomain transcription factor Prospero functions as a similar switch by repressing genes required for self-renewal, such as stem cell and cell-cycle genes, while activating genes involved in terminal differentiation ([@bib26]). Parallels from other biological systems may help elucidate whether T-bet similarly functions to promote terminal differentiation at the expense of self-renewal, which has been proposed to represent an essential distinction between effector-- versus central--memory CD8^+^ T cells, respectively ([@bib2]--[@bib7], [@bib27]).

The potential ability of T-bet to switch between two polar states of differentiation may explain numerous aspects of viral pathogenesis. Clonal deletion, for example, could be regarded as a "self-renewal deficiency state," associated with extreme excess of T-bet expression resulting from prolonged antigenic stimulation. Likewise, the association of high precursor frequency with enhanced central--memory formation might be considered a "disorder of excessive self-renewal," explained by diminished T-bet expression as a consequence of excessive competition for antigen ([@bib5]). The potential role of T-bet in these processes is currently being investigated.

The excessive differentiation of effector--memory CD8^+^ T cells in the absence of CD4^+^ T cell help could involve direct effects, such as loss of soluble or membrane-bound signals typically delivered by CD4^+^ T cells to dendritic cells or CD8^+^ T cells, including IL-2, chemokines, or CD40L ([@bib28]--[@bib30]). Alternatively, loss of CD4^+^ T cell help could act more indirectly, for example, by altering kinetics of pathogen clearance and necessitating prolonged effector function ([@bib3]). Although the abnormalities arising in the absence of CD4^+^ T cell help appear to be at least partially T-bet--dependent, it is anticipated there could be T-bet--independent derangements contributing to the aberrant differentiation of unhelped memory CD8^+^ T cells. Nonetheless, antagonism of T-bet might represent a novel therapeutic approach for preventing the dysfunctional programming of CD8^+^ T cells in patients with compromised CD4^+^ T cell function.

MATERIALS AND METHODS
=====================

Mice and pathogens.
-------------------

Mice were maintained and used in accordance with the University of Pennsylvania Institutional Animal Care and Use Guidelines. Wild-type C57BL/6, *Tbx21* ^−/−^ ([@bib18]), DO11.10 TCR transgenic, and P14 TCR transgenic mice were housed in specific pathogen-free conditions before use. *Tbx21* ^−/−^ P14 TCR transgenic mice were generated by interbreeding *Tbx21* ^−/−^ mice with P14 transgenic mice. For analysis of the endogenous CD8^+^ T cell response, C57BL/6 mice or *Tbx21* ^−/−^ were infected with 2 × 10^5^ PFU of LCMV Armstrong. H-2D^b^GP33 or H-2D^b^NP396 tetramers were used to identify LCMV-specific CD8^+^ T cells. For P14 transfer experiments, ∼5 × 10^4^ CD8^+^ T cells from naive P14 TCR transgenic mice (Thy1.1/1.1) were transferred intravenously into C57BL/6 or *Cd4* ^−/−^ recipients (Thy1.2/1.2). For P14 cotransfer experiments, ∼5 × 10^4^ wild-type P14 cells (Thy1.1/1.1) were mixed with ∼5 × 10^4^ *Tbx21* ^−/−^ P14 cells (Thy1.1/1.2) and transferred to wild-type C57BL/6 recipients (Thy1.2/1.2). 1 d after transfer, recipient mice were infected with LCMV. For CD4 depletion experiments, wild-type or *Tbx21* ^−/−^ mice received intraperitoneal injection of GK1.5 antibody (0.2 mg in PBS) 1 d before and 1 d after infection with LCMV. GK1.5 treatment resulted in efficient depletion of CD4^+^ T cells for \>1 wk (not depicted). For *Listeria monocytogenes* experiments, mice were challenged with 2.5 × 10^5^ CFU of *L. monocytogenes* with transgenic expression of the LCMV-derived peptide GP~33-41~. 4 d after bacterial challenge, spleens and livers were homogenized in 1% Triton X-100 in PBS, followed by limiting dilution culture on blood heart infusion agar.

Flow cytometry, cell culture, stimulation, and retroviral transduction.
-----------------------------------------------------------------------

Surface staining, intracellular cytokine staining, and flow cytometry were performed as previously described ([@bib18]). For LCMV-derived peptide stimulations, splenocytes or lymph node cells were stimulated for 6 h with 0.2 μg/ml GP~33-41~ or NP~396-404~ peptide in the presence of 1 μg/ml brefeldin A. Antibodies used for flow cytometry were purchased from BD Biosciences. Intranuclear T-bet staining (Santa Cruz Biotechnology) was performed by fixation with 4% paraformaldehyde in PBS, followed by permeabilization and staining in 0.1% Triton X-100 and 1% FBS in PBS. Splenocytes from DO11.10 or P14 TCR transgenic mice were stimulated and transduced as previously described ([@bib18]).

Quantitative RT-PCR.
--------------------

RNA extraction, cDNA synthesis, and quantitative real-time RT-PCR were performed as previously described ([@bib18]). Primer and probe sets used for HPRT and Eomes detection were previously described ([@bib18]). Presynthesized Taqman Gene Expression Assays (Applied Biosystems) were used to amplify the following sequences (gene symbols and Applied Biosystems primer set numbers in parentheses): Blimp-1 (*Prdm1*; Mm00476128_m1), CCR7 (*Ccr7*; Mm01301785_m1), KLRG1 (*Klrg1*; Mm00516879_m1), and T-bet (*Tbx21*; Mm00450960_m1). 'Test' gene values are expressed relative to that of HPRT, with the lowest experimental value standardized at 1.

Online supplemental material.
-----------------------------

Fig. S1 shows that T-bet--deficient antigen-specific memory CD8^+^ T cells preferentially accumulate in lymph nodes. Fig. S2 shows that T-bet represses central--memory development in a CD8^+^ T cell--intrinsic manner. Fig. S3 shows that deletion of T-bet rescues the phenotype and function of unhelped memory CD8^+^ T cells. Fig. S4 shows that unhelped memory CD8^+^ T cells have elevated expression of T-bet. Fig. S5 shows that T-bet deficiency restricted to antigen-specific CD8^+^ T cells is capable of correcting abnormalities associated with unhelped memory cells. Fig. S6 shows that preexisting dysfunction in unhelped memory CD8^+^ T cells can be reversed by antagonism of T-bet. The online version of this article is available at <http://www.jem.org/cgi/content/full/jem.20070841/DC1>.
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